Rapaccini, Gian Ludovico
 Distribuzione geografica
Continente #
EU - Europa 6.185
NA - Nord America 5.640
AS - Asia 1.125
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 19
OC - Oceania 14
Totale 13.047
Nazione #
US - Stati Uniti d'America 5.612
DE - Germania 2.465
SE - Svezia 1.313
CN - Cina 774
UA - Ucraina 568
IT - Italia 527
IE - Irlanda 401
FR - Francia 276
GB - Regno Unito 216
FI - Finlandia 172
IN - India 113
TR - Turchia 112
PL - Polonia 64
BE - Belgio 47
CI - Costa d'Avorio 35
JP - Giappone 31
RU - Federazione Russa 21
CH - Svizzera 18
IR - Iran 18
NL - Olanda 18
HK - Hong Kong 17
CZ - Repubblica Ceca 16
EU - Europa 16
SG - Singapore 16
VN - Vietnam 14
BZ - Belize 13
CA - Canada 13
RO - Romania 13
AU - Australia 11
TW - Taiwan 10
BR - Brasile 9
ES - Italia 7
GR - Grecia 7
PT - Portogallo 7
AT - Austria 6
CL - Cile 6
DK - Danimarca 5
HU - Ungheria 4
KR - Corea 4
NZ - Nuova Zelanda 3
SC - Seychelles 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BY - Bielorussia 2
IL - Israele 2
MK - Macedonia 2
NO - Norvegia 2
PH - Filippine 2
RE - Reunion 2
SD - Sudan 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 13.047
Città #
Chandler 1.208
Ashburn 444
Dublin 400
Jacksonville 320
New York 256
San Mateo 250
Nanjing 226
Ann Arbor 163
Nürnberg 162
Wilmington 156
Boston 142
Dearborn 139
Houston 128
Princeton 125
Izmir 102
Milan 102
Chicago 99
Marseille 99
Cattolica 87
Beijing 82
Woodbridge 79
Nanchang 69
Los Angeles 68
Bremen 61
Redwood City 61
Helsinki 60
Redmond 60
Seattle 59
Munich 58
Fairfield 52
Kraków 52
Rome 50
Shenyang 46
Brussels 45
San Jose 42
Lawrence 41
Hebei 38
Lancaster 36
Abidjan 35
Mountain View 34
Norwalk 33
Tianjin 33
Zhengzhou 31
Kunming 30
University Park 29
Hangzhou 28
Pune 27
Changsha 25
Leawood 24
Augusta 23
Jiaxing 22
Boardman 20
Guangzhou 20
Falls Church 19
Jinan 19
Detroit 18
Shanghai 18
Edinburgh 17
Las Vegas 17
Buffalo 14
Castelnuovo di Val di Cecina 14
Hong Kong 14
Belize City 13
Hanoi 13
Washington 13
Fremont 12
Hefei 12
Lanzhou 12
Warsaw 12
Andover 11
Brno 10
Cambridge 10
London 10
Tokyo 10
Zurich 10
Atlanta 9
Costa Mesa 9
Kish 9
San Diego 9
Simi Valley 9
Taipei 9
Auburn Hills 8
Bologna 8
Changchun 8
Phoenix 8
Portland 8
Singapore 8
Boydton 7
Cagliari 7
Sacramento 7
Taizhou 7
Albuquerque 6
Bern 6
Kocaeli 6
Saint Louis 6
Toronto 6
Busto Arsizio 5
Lappeenranta 5
Millbury 5
Ningbo 5
Totale 6.559
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 378
Association between Klinefelter syndrome and focal nodular hyperplasia 256
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 202
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 178
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 177
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 173
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 172
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 156
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 149
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 144
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 140
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 139
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 138
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 137
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 136
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 133
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 131
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 130
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 127
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 126
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 126
recurrent acute hepatitis associated with use of cetrizine 123
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 122
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 121
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 118
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 116
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 114
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 110
Potential use of liver function breath tests in the clinical practice. 107
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 106
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 96
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 94
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 93
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 92
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 92
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 92
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 91
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 88
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 87
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 86
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 86
Liver transplantation in patients with alcoholic liver disease: A retrospective study 86
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 85
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 85
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 85
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 85
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 84
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 83
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 82
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 82
[Liver transplantation] 81
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 81
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 79
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 76
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 76
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 76
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 74
Is coeliac disease a confounding factor in the diagnosis of NASH? 72
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 72
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 71
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 71
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 71
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 69
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 69
Impairment of recent thymic emigrants in HCV infection. 68
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 68
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 68
Sarilumab use in severe SARS-CoV-2 pneumonia 68
Immunological role of IgG subclasses 67
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 66
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 66
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 65
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 65
Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma 64
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 64
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 63
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome 63
Acute hepatitis associated with use of paroxetine 62
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation 62
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 62
Cruveilhier-Baumgarten syndrome: an efficient spontaneous portosystemic collateral preventing oesophageal varices bleeding 61
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 61
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy 60
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 60
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 60
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 60
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 60
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 60
Primary neoplasm of the duodenum diagnosed by echo-guided fine-needle biopsy 59
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 59
The Laboratory Role in anti-TNF Biological Therapy Era 59
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 59
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 59
Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel diseases 58
Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management 58
Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients 58
The Italian experience on paediatric liver transplantation: 1988-1999 report 57
Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. 57
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 57
Totale 9.537
Categoria #
all - tutte 50.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019303 0 0 0 0 0 0 0 0 0 0 167 136
2019/20201.656 334 103 90 58 144 207 150 82 103 109 139 137
2020/20211.225 67 114 46 141 149 41 115 28 168 58 260 38
2021/20221.642 110 118 39 140 102 54 34 221 66 107 283 368
2022/20233.736 476 436 268 501 296 434 227 314 446 97 163 78
2023/20241.669 115 556 64 135 82 355 113 88 26 125 10 0
Totale 13.301